scholarly journals Serological Evidence for a Hepatitis E Virus-Related Agent in Goats in the United States

2012 ◽  
Vol 60 (6) ◽  
pp. 538-545 ◽  
Author(s):  
B. J. Sanford ◽  
S. U. Emerson ◽  
R. H. Purcell ◽  
R. E. Engle ◽  
B. A. Dryman ◽  
...  
Keyword(s):  
United States ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
The United States ◽  
Serological Evidence ◽  
Related Agent

Hepatitis E Virus Infection in an Immigrant to the United States

1996 ◽  
Vol 89 (10) ◽  
pp. 994-996 ◽  
Author(s):  
DAVID L. SMALLEY ◽  
SUSAN C. BREWER ◽  
GEORGE J. DAWSON ◽  
CHARLES KYRK ◽  
BRADFORD WATERS
Keyword(s):  
United States ◽  
Virus Infection ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
The United States

scholarly journals 290. Hepatitis E Virus Serostatus: A Retrospective Assessment of Demographics and Comorbidities to Assess High-risk Populations

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S158-S158
Author(s):  
Eric C Stone ◽  
Zerelda Esquer Garrigos ◽  
Muhammad R Sohail ◽  
Raymund R Razonable ◽  
John C O’Horo
Keyword(s):  
United States ◽  
Liver Disease ◽  
Hepatitis E Virus ◽  
Kidney Diseases ◽  
Hepatitis E ◽  
The United States ◽  
Population Based ◽  
Positive Serology ◽  
Serologic Testing ◽  
One Year

Abstract Background Demographic and epidemiologic characteristics of Hepatitis E virus (HEV) infected patients in the United States are not well-described. HEV infection may result in severe complications and lead to chronic infection and cirrhosis, especially in immunocompromised patients. There are no widely accepted guidelines for HEV screening and testing in the United States. Identifying traits of known seropositive patients and comorbidities may inform better screening and prevention strategies. In this study, we describe rates of liver disease, transplant status, chronic kidney diseases, and diabetes mellitus among patients serologically tested for HEV at our institution. Methods We retrospectively reviewed all patients for whom HEV IgM or IgG serologic testing was performed across the Mayo Clinic enterprise using the Advanced Cohort Explorer tool. For patients with any documented HEV serologic test, we abstracted baseline patient characteristics and underlying comorbidities at the time of testing. We then grouped subjects according to serologic testing results by antibody type. Survival at one year from date of testing was also assessed. Results A total of 979 unique subjects were identified. The preponderance of subjects was Caucasian (781, 79.8%). Of subjects tested for HEV with serology, 123 (12.6%) had any positive serology. Breakdown of baseline characteristics and selected comorbidities are summarized in Table 1. The largest proportion of subjects, 458 (46.8%), were both IgG and IgM negative and 432 subjects received only IgM or IgG testing. Liver disease was more prevalent in patients with positive vs. negative testing (5.8% vs. 2.1%) as was higher age (average 55.1 years vs. 52.2). One-year survival was similar in all groups. Conclusion HEV serology is not commonly tested. Among those tested, seropositivity is uncommon. Our data show higher HEV seropositivity in older adults, which may represent increase risk of exposure over time. Higher percentage of positive testing was also observed in subjects with liver disease, which may indicate a possible etiologic association. Further population-based studies are needed to estimate prevalence of HEV infection and associated liver disease, outcomes in infected patients, and indications for testing in at-risk populations. Disclosures All authors: No reported disclosures.

Evidence for widespread infection of wild rats with hepatitis E virus in the United States.

1999 ◽  
Vol 61 (2) ◽  
pp. 331-335 ◽  
Author(s):  
Y Kabrane-Lazizi ◽  
G E Glass ◽  
H Higa ◽  
A Diwan ◽  
C J Gibbs ◽  
...  
Keyword(s):  
United States ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
The United States ◽  
Wild Rats

scholarly journals Prevalence of Antibody to Hepatitis E Virus among Rodents in the United States

2000 ◽  
Vol 181 (2) ◽  
pp. 449-455 ◽  
Author(s):  
Michael O. Favorov ◽  
Michael Y. Kosoy ◽  
Sergei A. Tsarev ◽  
James E. Childs ◽  
Harold S. Margolis
Keyword(s):  
United States ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
The United States

scholarly journals Decline in Hepatitis E Virus Antibody Prevalence in the United States From 1988–1994 to 2009–2010

2014 ◽  
Vol 211 (3) ◽  
pp. 366-373 ◽  
Author(s):  
Eyasu H. Teshale ◽  
Maxine M. Denniston ◽  
Jan Drobeniuc ◽  
Saleem Kamili ◽  
Chong-Gee Teo ◽  
...  
Keyword(s):  
United States ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
The United States ◽  
Virus Antibody ◽  
Antibody Prevalence

scholarly journals Current epidemiology of hepatitis E virus infection in the United States: Low seroprevalence in the National Health and Nutrition Evaluation Survey

Hepatology ◽  
2014 ◽  
Vol 60 (3) ◽  
pp. 815-822 ◽  
Author(s):  
Ivo Ditah ◽  
Fausta Ditah ◽  
Pardha Devaki ◽  
Calistus Ditah ◽  
Patrick S. Kamath ◽  
...  
Keyword(s):  
United States ◽  
Virus Infection ◽  
National Health ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
The United States ◽  
Health And Nutrition ◽  
Evaluation Survey

scholarly journals Heterogeneity and Seroprevalence of a Newly Identified Avian Hepatitis E Virus from Chickens in the United States

2002 ◽  
Vol 40 (11) ◽  
pp. 4197-4202 ◽  
Author(s):  
F. F. Huang ◽  
G. Haqshenas ◽  
H. L. Shivaprasad ◽  
D. K. Guenette ◽  
P. R. Woolcock ◽  
...  
Keyword(s):  
United States ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
The United States ◽  
Avian Hepatitis E Virus

scholarly journals Complete Genome Sequence of a Rat Hepatitis E Virus Strain Isolated in the United States

2014 ◽  
Vol 2 (6) ◽  
Author(s):  
Y. Debing ◽  
S. U. Emerson ◽  
R. H. Purcell ◽  
J. Neyts ◽  
K. Dallmeier
Keyword(s):  
United States ◽  
Genome Sequence ◽  
Virus Strain ◽  
Complete Genome Sequence ◽  
Complete Genome ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
The United States
Sign in / Sign up

Export Citation Format

Share Document